Transposagen Biopharmaceuticals announces new TGEM Rat Model product line

[News]

Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it has added 170 genetically modified rats and related biomaterials to its database of laboratory rats with a genetic modification that can mimic a human disease. These animals are used by academic, pharmaceutical, and biotech scientists for drug discovery and development research and will be sold under Transposagen's new TGEM(TM) Rat Models brand.

More... (http://www.news-medical.net/news/20100423/Transposagen-Biopharmaceuticals-announces-new-TGEM-Rat-Model-product-line.aspx)